NASDAQ · ONMDTechnologyR&D — Physical & Biological Sciences

OneMedNet Corp Class A Common Stock (ONMD)

$4.17−8.15%
Close Nov 5, 2026 · split-adjusted
Nov 5, 2026$4.17▼ 76.17% in range
Nov 5, 2025Low $3.93 · High $63.30Nov 5, 2026
What changed · written from our data
As of Nov 5, 2026

OneMedNet closed at $4.17 on Nov 5, down 8.15%, 93.4% below its 52-week closing high. Volume of 17.7K shares was 0.63× its 20-day average (below normal).

Split-adjusted performance: -15.1% over one month, -57.3% over six months, -76.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $292K, up 88.4% from a year earlier, with a net margin of -743.8%.

Short interest was 151.0K shares at the Oct 15 settlement, up 33.0% from the prior report (0.7% of float, 3.5 days to cover).

Market cap$24.3M5.8M shares
Revenue · quarter$292.0K+88.4% YoY
Diluted EPS$-0.40−157.1% YoY
P/E · TTM—P/S 16.7×
Net margin-743.8%Gross -193.5%
Dividend yieldNone
52-week range3.93 – 63.30−93.4% from high
Volume17.7K0.63× 20-day avg
Volatility · 60d699.2%Annualised
Short % of float0.7%3.5 days to cover
Net cash-$343.0KCash $358.0K
Next earnings—Not scheduled
Split-adjusted performance
1W −4.6%1M −15.1%3M −33.2%6M −57.3%YTD −62.1%1Y −76.3%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within R&D — Physical & Biological Sciences

Percentile among 11 companies (100 = best)

6-month momentum20
Revenue growth100
Net margin20
Value (low P/E)—
Size20

Industry medians: 6-month return +48.1%, revenue growth +8.5%, net margin −122.0%, P/E 47.0×.

Short interest

Details →
Shares short151.0K+33.0% vs prior
Days to cover3.5Settled Oct 15
% of float0.7%
Short vol. 10d48.1%of daily volume

Closest peers by size in R&D — Physical & Biological Sciences

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ONMDOneMedNet$4.17−8.15%−57.3%+88.4%−743.8%—$24.3M
IBACIB Acquisition$10.81−0.46%−0.2%———$54.1MCompare
MXCTMaxCyte$1.31−5.76%+50.3%−14.5%−122.0%—$135.2MCompare
ISPCiSpecimen$0.8079−4.16%−84.7%−78.7%−896.9%—$2.0MCompare
BIAFbioAffinity Technologies$2.60−11.26%−91.8%+19.0%−222.8%—$1.6MCompare
NRCNRC Health$25.48−5.87%+36.0%+11.0%12.3%88.2$540.7MCompare
OABIOmniAb$4.83−6.76%+228.6%+78.3%−393.9%—$704.5MCompare
ABSIAbsci$9.39−10.40%+63.3%−46.4%−10443.4%—$1.61BCompare
CRLCharles River Laboratories International$313.02−4.07%+72.3%−2.7%−0.1%—$15.00BCompare

Quick answers

What does OneMedNet do?
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM).
What is ONMD's market cap?
$24.29M, based on the Nov 5 close of $4.17.
Does OneMedNet pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ONMD is sold short?
151.0K shares, 0.7% of float, as of Oct 15, 2026.
What sector is ONMD in?
Technology, in the R&D — Physical & Biological Sciences industry.

About OneMedNet

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

HQ: Surrey, X023 employeesListed Nov 8, 2023onemednet.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology